These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

573 related articles for article (PubMed ID: 15350333)

  • 1. Treatment of recurrent corneal and conjunctival intraepithelial neoplasia with topical interferon alfa 2b.
    Boehm MD; Huang AJ
    Ophthalmology; 2004 Sep; 111(9):1755-61. PubMed ID: 15350333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of conjunctival and corneal epithelial neoplasia with retinoic acid and topical interferon alfa-2b: long-term follow-up.
    Krilis M; Tsang H; Coroneo M
    Ophthalmology; 2012 Oct; 119(10):1969-73. PubMed ID: 22704834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perilesional and topical interferon alfa-2b for conjunctival and corneal neoplasia.
    Vann RR; Karp CL
    Ophthalmology; 1999 Jan; 106(1):91-7. PubMed ID: 9917787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regression of presumed primary conjunctival and corneal intraepithelial neoplasia with topical interferon alpha-2b.
    Schechter BA; Schrier A; Nagler RS; Smith EF; Velasquez GE
    Cornea; 2002 Jan; 21(1):6-11. PubMed ID: 11805499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up of conjunctival and corneal intraepithelial neoplasia treated with topical interferon alfa-2b.
    Schechter BA; Koreishi AF; Karp CL; Feuer W
    Ophthalmology; 2008 Aug; 115(8):1291-6, 1296.e1. PubMed ID: 18187195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of conjunctival and corneal intraepithelial neoplasia with topical interferon alpha-2b.
    Karp CL; Moore JK; Rosa RH
    Ophthalmology; 2001 Jun; 108(6):1093-8. PubMed ID: 11382635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical Interferon α-2b as a Single Therapy for Primary Ocular Surface Squamous Neoplasia.
    Kusumesh R; Ambastha A; Sinha B; Kumar R
    Asia Pac J Ophthalmol (Phila); 2015; 4(5):279-82. PubMed ID: 26176194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term results of topical mitomycin C 0.02% for primary and recurrent conjunctival-corneal intraepithelial neoplasia.
    Ballalai PL; Erwenne CM; Martins MC; Lowen MS; Barros JN
    Ophthalmic Plast Reconstr Surg; 2009; 25(4):296-9. PubMed ID: 19617789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical versus medical treatment of ocular surface squamous neoplasia: a comparison of recurrences and complications.
    Nanji AA; Moon CS; Galor A; Sein J; Oellers P; Karp CL
    Ophthalmology; 2014 May; 121(5):994-1000. PubMed ID: 24411578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical interferon alfa-2b for management of ocular surface squamous neoplasia in 23 cases: outcomes based on American Joint Committee on Cancer classification.
    Shah SU; Kaliki S; Kim HJ; Lally SE; Shields JA; Shields CL
    Arch Ophthalmol; 2012 Feb; 130(2):159-64. PubMed ID: 22332208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent intraepithelial neoplasia treatment.
    Schechter BA; Nagler RS; Schrier A
    Ophthalmology; 2005 Jul; 112(7):1319; author reply 1319. PubMed ID: 15993243
    [No Abstract]   [Full Text] [Related]  

  • 12. Safety and efficacy of topical interferon alpha 2B and mitomycin C for localized conjunctival intraepithelial neoplasia: long-term report of their pharmacological safety and efficacy.
    Alvarado-Castillo B; Santa Cruz-Pavlovich FJ; Gonzalez-Castillo C; Vidal-Paredes IA; Garcia-Benavides L; Rosales-Gradilla ME; Navarro-Partida J
    BMC Ophthalmol; 2023 Jul; 23(1):335. PubMed ID: 37501105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Giant ocular surface squamous neoplasia managed with interferon alpha-2b as immunotherapy or immunoreduction.
    Kim HJ; Shields CL; Shah SU; Kaliki S; Lally SE
    Ophthalmology; 2012 May; 119(5):938-44. PubMed ID: 22361315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Topical interferon alfa-2b for primary treatment of conjunctiva-cornea intraepithelial neoplasia].
    Pérez de Arcelus M; Aranguren M; Andonegui J
    An Sist Sanit Navar; 2012; 35(1):137-41. PubMed ID: 22552136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for ocular surface squamous neoplasia recurrence after treatment with topical mitomycin C and interferon alpha-2b.
    Besley J; Pappalardo J; Lee GA; Hirst LW; Vincent SJ
    Am J Ophthalmol; 2014 Feb; 157(2):287-293.e2. PubMed ID: 24184223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical interferon alfa-2b for the treatment of recalcitrant ocular surface squamous neoplasia.
    Holcombe DJ; Lee GA
    Am J Ophthalmol; 2006 Oct; 142(4):568-71. PubMed ID: 17011846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-Fluorouracil for the treatment of intraepithelial neoplasia of the conjunctiva and cornea.
    Yeatts RP; Engelbrecht NE; Curry CD; Ford JG; Walter KA
    Ophthalmology; 2000 Dec; 107(12):2190-5. PubMed ID: 11097594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical interferon alfa in the treatment of conjunctival melanoma and primary acquired melanosis complex.
    Finger PT; Sedeek RW; Chin KJ
    Am J Ophthalmol; 2008 Jan; 145(1):124-129. PubMed ID: 17981257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subconjunctival/perilesional recombinant interferon α2b for ocular surface squamous neoplasia: a 10-year review.
    Karp CL; Galor A; Chhabra S; Barnes SD; Alfonso EC
    Ophthalmology; 2010 Dec; 117(12):2241-6. PubMed ID: 20619462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of recurrent corneal intraepithelial neoplasia with topical mitomycin C.
    Tseng SH; Tsai YY; Chen FK
    Cornea; 1997 Sep; 16(5):595-7. PubMed ID: 9294697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.